Mandarin Capital Acquires Stakes In Italian Drug Firm Mipharm

Login to View

Mandarin Capital Partners has acquired a majority stake in Mipharm Spa, an Italian contract manufacturing organization engaged in the manufacturing and packaging of a wide range of drugs, the Sino-Europe private equity firm said today.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS